Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma

International Journal of Cancer

Volumn 135, Issue 8, 2014, Pages 1790-1799

  Lai, Keng Po ^a   Chen, Jiawei ^a   He, Mian ^a   Ching, Arthur K K ^a   Lau, Coleen ^a   Lai, Paul B S ^b   To, Ka Fai ^a,b   Wong, Nathalie ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

chemoresistance; hepatocellular carcinoma; self renewal; ZFX

Indexed keywords

TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN X LINKED;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER GROWTH; CANCER RESISTANCE; CELL CYCLE G0 PHASE; CELL PROLIFERATION; CELL RENEWAL; COLONY FORMATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

CHEMORESISTANCE; HEPATOCELLULAR CARCINOMA; SELF-RENEWAL; ZFX;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PEPTIDES; SOXB1 TRANSCRIPTION FACTORS; TUMOR BURDEN;

EID: 84905752304     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28819     Document Type: Article

References (28)

1. Li Y, Tang ZY, Hou JX,. Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol 2011; 9: 32-43.
2. Motola-Kuba D, Zamora-Valdés D, Uribe M, et al. Hepatocellular carcinoma. An overview. Ann Hepatol 2006; 5: 16-24.
3. Chiba T, Kamiya A, Yokosuka O, et al. Cancer stem cells in hepatocellular carcinoma: recent progress and perspective. Cancer Lett 2009; 286: 145-53.
4. Tong CM, Ma S, Guan XY,. Biology of hepatic cancer stem cells. J Gastroenterol Hepatol 2011; 26: 1229-37.
5. Ma S, Tang KH, Chan YP, et al. miR-130b promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 2010; 7: 694-707.
6. Woo HG, Wang XW, Budhu A, et al. Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology 2011; 140: 1063-70.
7. Oishi N, Wang XW,. Novel therapeutic Strategies for targeting liver cancer stem cells. Int J Biol Sci 2011; 7: 517-35.
8. Galan-Caridad JM, Harel S, Arenzana TL, et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 2007; 129: 345-57.
9. Cellot S, Sauvageau G,. Zfx: at the crossroads of survival and self-renewal. Cell 2007; 129: 239-41.
10. Huang D, Gao Q, Guo L, et al. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev 2009; 18: 465-73.
11. Akiyoshi S, Fukagawa T, Ueo H, et al. Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br J Cancer 2012; 107: 1345-53.
12. Jiang H, Zhang L, Liu J, et al. Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9. Cancer Gene Ther 2012; 19: 684-9.
13. Zhou Y, Su Z, Huang Y, et al. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. J Exp Clin Cancer Res 2011; 30: 114.
14. Gho J, Ip WK, Chan KY, et al. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2/M arrest. Cancer Res 2008; 68: 6743-6751.
15. Wang XQ, Ongkeko WM, Chen L, et al. Octamer 4 (OCT4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential OCT4-AKT-ATP-binding cassette G2 pathway. Hepatology 2010; 52: 528-39.
16. Liu H, Yu X, Li K, et al. Photoexcited CRY2 interacts with CIB1 to regulate transcription and floral initiation in Arabidopsis. Science 2008; 322: 1535-39.
17. Masui S, Nakatake Y, Toyooka Y, et al. Pluripotency governed by SOX-2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 2007; 9: 625-35.
18. Chen X, Xu H, Yuan P, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008; 133: 1106-17.
19. Heidel FH, Mar BG, Armstrong SA,. Self-renewal related signaling in myeloid leukemia stem cells. Int J Hematol 2011; 94: 109-17.
20. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-88.
21. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-10.
22. Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008; 321: 699-702.
23. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797-801.
24. Jeter CR, Badeaux M, Choy G, et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009; 27: 993-1005.
25. Lu Y, Futtner C, Rock JR, et al. Evidence that SOX-2 overexpression is oncogenic in the lung. PLoS One 2010; 5: e11022.
26. Sholl LM, Barletta JA, Yeap BY, et al. SOX-2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol 2010; 34: 1193-8.
27. Tsai LL, Yu CC, Chang YC, et al. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol Med 2011; 40: 621-8.
28. Lu Y, Zhu H, Shan H, et al. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Lett 2013; 340: 113-23.